Navigation Links
UBM TechInsights Issues Warning to Medical Devices Industry About Possible Obsolescence as Reliance on Smartphones Increases
Date:2/7/2011

ANAHEIM, Calif., Feb. 7, 2011 /PRNewswire/ -- UBM TechInsights today warned the consumer medical device industry that the smartphone juggernaut will impact revenues, design strategies, and intellectual property (IP) management for medical devices in the same way it has for many consumer products including cameras, GPS devices and personal media players.

"The question for traditional medical device companies is whether their designers, marketers and IP staff have factored the smartphone platform into their thinking," said Jeff Brown, vice president of business intelligence for UBM TechInsights. "Smartphones provide medical technology companies with unprecedented access to an enormous consumer market. To capture this opportunity, they must think carefully about how they develop new technologies and protect their intellectual property innovations. Otherwise, they face the same fate as makers of stand-alone GPS and MP3 players – a slow decline to obsolescence."

Brown is communicating this message today at Medical Design & Manufacturing (MD&M) West, during a seminar entitled "Managing the Electronic Medical Device Lifecycle from Standalone Innovation to Converged Capability."

Innovation in the electronic medical devices industry is accelerating, enabling breakthrough methods of administering treatments and improving patient care. Initially, these sophisticated electronic medical devices, like many advances in consumer electronics, appear as standalone units with high price tags and low sales volume. Over time, successful device categories attract competitors that drive product evolution in one of two directions: improving the original stand-alone format, or converging functionality with a larger, established market.

Using UBM TechInsights' product profile database built from over 1000 product teardowns of consumer electronic devices and smartphones, Brown has traced the technology lifecycle of consumer electronics innovations as they have diverged along these two paths and examined how electronic medical device technologies will progressively converge with smartphones.

The core elements of many personal medical devices – including processors, displays, memory, keyboard/data-entry methods, battery power, connectivity methods, speaker/headphones, and sensors – are being found increasingly in smartphones. Driven by apps, video, and gaming, smartphones have also become more sophisticated, boasting greater processing power and better sensors.  

As a result, electronics designers can now deliver valuable medical device functionality at a lower marginal cost through integration with smartphones. Lower prices to consumers who already possess smartphones increase the addressable market for integrated products as compared to more expensive, stand-alone medical devices.

Integration often appears first as a physical connection between the smartphone and a specialized sensor through a cable or wireless technology. An example is the Nike + iPod Sport Kit that adds pedometer and pulse meter functionality to the iPhone, augmented with a "personal trainer" application for tracking time, distance, pace, and calories burned. Subsequent stages of integration include physical packaging, sometimes with "sleeves" for specialized sensor functionality like the AliveCor iPhone ECG, then ultimately complete integration employing onboard smartphone sensors, like the iStethoscope.  The potential for personal wellness and medical applications development on smartphone devices, including the charting of results and access to related medical information, opens new areas for added value not available from traditional stand-alone medical devices.

"Medical device functionality in smartphones is often rudimentary to start, compared to stand-alone devices," continued Brown. "However, smartphone implementations come with the advantage of being conveniently at hand and ready for use at all times, and usually at a significantly lower cost to the consumer. Over time, medical technology innovations improve the precision and reliability of implementations on smartphones so that they rival – or, when combined with apps – even surpass stand-alone devices."

Brown and other executives will be on hand at MD&M West and the co-located DesignMED conference and exposition, taking place at the Anaheim Convention Center in California today through February 10, 2011. UBM TechInsights will be showcasing its portfolio of intellectual property consulting, business intelligence, and technical intelligence products and services at its booth, #7238, located in the Ballroom, Level 3.  

For more information on Brown's predictions, or for a copy of his presentation, please contact UBM TechInsights at busintelligence@ubmtechinsights.com.

About UBM TechInsights

UBM TechInsights provides professional services and essential intelligence to manage technology and Intellectual Property (IP) portfolios. With over 20 years of experience in technical analysis and IP matters UBM TechInsights provides a comprehensive IP management process that delivers maximum strategic advantage and financial returns for customers around the world. The company provides information and customized services in IP, Technical Intelligence, and Business Intelligence for each stage of the IP lifecycle. Global markets served include Automotive, Clean Technologies, Consumer Electronics, Investment, Legal, Medical Devices, Semiconductors, and Software. For more information, please visit www.ubmtechinsights.com.


'/>"/>
SOURCE UBM TechInsights
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. UBM TechInsights Expands Presence in the Medical Devices Sector
2. UBM TechInsights Launches Product Teardowns for Medical Electronics
3. The First Annual Cervical Cancer/HPV Conference Tackles Controversial Vaccine Issues and Encourages Advocacy
4. European Unions CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy
5. European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg)
6. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
8. QIAGEN and Center for Molecular Medicine Create Research Collaboration for Molecular Diagnostic Markers for Breast Cancer, Other Womens Health Issues
9. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Bioniche Life Sciences Inc.
10. Lupus Under the Spotlight: U.S. Congress Shows Support for Womens Health Issues
11. European Unions CHMP Issues Positive Opinion on Sugammadex
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... April 29, 2016  In the next ten ... shift from systems dependent on CRTs monitors to those ... modality CRT Medical monitors and will automatically sync ... host of foreseeable benefits to this technological advancement, ... modalities have to be replaced in order to ...
(Date:4/29/2016)... 29, 2016 Glycotope GmbH, a ... announces the appointment of Dr. Alfredo Zurlo ... an oncologist with many years clinical experience and a ... His last role was at Mologen AG where he ... Board. Previously Dr. Zurlo held various positions at F ...
(Date:4/28/2016)... April 28, 2016 Research and ... Plastic Surgery Products Market 2016-2020" report to their ... , The global plastic surgery products market ... during the period 2016-2020. , ,The growing adoption of ... the growth of the market. Lasers are used to ...
Breaking Medicine Technology:
(Date:5/3/2016)... Monica, CA (PRWEB) , ... May 03, 2016 , ... ... the highest quality medical providers to build the leading network of doctors and therapists ... Eric Nepomnaschy, D.C., founder of the distinguished Bay Chiropractic and Rehabilitation in ...
(Date:5/3/2016)... ... May 03, 2016 , ... SELEX (systematic evolution ... from a random library of sequences depending on their attraction for a target ... SELEX selection is commonly performed using filters, panning, or affinity chromatography separations. However, ...
(Date:5/3/2016)... FL (PRWEB) , ... May 03, 2016 , ... ... leading innovative specialty pharmacies, will be represented at the 2016 Asembia Specialty ... Vegas. The Asembia Summit is the largest U.S. health care conference for the ...
(Date:5/3/2016)... ... May 03, 2016 , ... Boston Children’s Hospital today announced its ... situations or practice tricky or rare procedures in an environment that looks and feels ... is also available to inventors and “hackers” to develop and test new devices or ...
(Date:5/3/2016)... ... May 03, 2016 , ... ... announces Benefits Alliance Insurance Services as the latest addition to its elite stable ... comprised of Partners Wayne Blasman, David Styles, and Paul Vincent. The Firm is ...
Breaking Medicine News(10 mins):